M.V. Poel

Discipline

Psychologie (1)

Type de document

Co-auteur

P. Westerweel

O. Weerdt

E. Vellenga

W.V. Velden

M.C. Vekemans

L. Tick

W. Terpstra

G. Stussi

O. Spertini

H. Sinnige

T. Pabst

G. Ossenkoppele

M. Oosterveld

F.V. Obbergh

Y.V. Norden

M. Nijziel

I. Moors

M. Manz

J. Maertens

B. Löwenberg

A.V. Loosdrecht

M.C. Legdeur

D.V. Lammeren-Venema

J. Kuball

MVM Kooy

M.V. Klift

S. Klein

M. Jongen-Lavrencic

A. Jie

A. Jaspers

J. Janssen

M. Hoogendoorn

U. Hess

D. Heim

M. Gregor

C. Graux

B.T. Gjertsen

A. Efthymiou

D. Deeren

Y. Chalandon

R. Brouwer

D. Breems

PVD Borne

B. Biemond

M. Bargetzi

Date

Source

Serveur académique Lausannois (1)

Mot-clé

puits (1) norme (1) spectacle (1) risque (1) dose (1) âge (1) procès (1) taux (1) survie (1) Treatment (1) Chemotherapy (1) Complications (1) Rates (1) Survival (1) Risk (1) Population (1) Patients (1) Adjustable rate mortgages (1) Months (1) Days (1) Chemotherapy (1) Atrial fibrillation (1) Arm (1) Age (1) Addition (1) Premature death (1) Age (1) Rates (1) Population (1) Patients (1)

Documents écrit par M.V. Poel (1) | parle de M.V. Poel (0)

Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS.

J. Janssen et al. (7 févr. 2021)